# Contrafect Announces FDA Clearance Of CF-370 IND Application To Proceed With Phase 1 Clinical Study, shares +33% premarket
**FDA Update**

**2023-10-16 11:40**

**https://www.ainvest.com/news/contrafect-announces-fda-clearance-of-cf-370-ind-application-to-proceed-with-phase-1-clinical-study-shares-33-premarket-231010006a42f7049a60a079/**

Contrafect Announces FDA Clearance Of CF-370 IND Application To Proceed With Phase 1 Clinical Study, shares +33% premarket